METHODS

Study Design & Data Source
• Retrospective, cross-sectional database analysis using 2011 -2014 data from the Japan National Health and Wellness Survey (NHWS), a representative, self-administered, Internet-based questionnaire surveying adults in Japan aged 18 or older.
Sample
• Since it is possible for a respondent to complete more than one survey over this four-year period, only the most recent data for a given respondent was kept in these instances (e.g., if a respondent participated in 2011 and 2013, only the 2013 data was kept and used for analyses).
• All unique respondents from the 2011-2014 Japan NHWS were preliminarily included in the analyses (N=115,271).
Variables
Fibromyalgia
• Respondents who self-reported a diagnosis of fibromyalgia by a healthcare provider were considered to have fibromyalgia. All other respondents were considered not to have fibromyalgia (i.e., control respondents). A propensity score matching methodology was used to match fibromyalgia respondents with control respondents based on demographics and health characteristics. Demographic and health characteristics • Demographic characteristics included year of survey, gender, age, education, household income, and health insurance.
• Health characteristics included smoking habits, exercise behavior, alcohol use, body mass index (BMI), and the Charlson comorbidity index (CCI). Economic Outcomes • Work productivity loss and activity impairment: Work productivity loss and activity impairment were measured via the Work Productivity and Activity Impairment-General Health scale (WPAI-GH). 
Statistical Analyses
• A greedy-matching algorithm 6 was used to match respondents who self-reported a diagnosis of fibromyalgia (n=128) with those without fibromyalgia (n=128).
• One-way analysis of variance (continuous variables) or chi-square tests (categorical variables) were used to compare demographic and health characteristics between those with fibromyalgia and those without fibromyalgia (matched controls).
• Post-match, if any demographic or health characteristic variables differed between groups, 7 then, a series of generalized linear models were conducted to predict each outcome specifying the appropriate distribution (negative binomial with log-link functions for work productivity and activity impairment, resource utilization, and cost data due to pronounced skew).
-These models had fibromyalgia status (yes vs. no) as the primary independent variable and any variables which significantly differed between them as covariates. -Adjusted means and 95% confidence intervals were reported.
• Any two-sided p-values less than 0.05 were considered statistically significant.
RESULTS
Sample demographics and matching results
• Sample mean age was 44.5 years (SD=15.0); 62.5% were female.
• Of those who reported fibromyalgia (n=128), the average age was 42.62 (SD=14.34) years old; 59.4%
were female ( Table 1 ).
• At post-match, imbalance was observed between several groups (standardized effect sizes >0.10, see Table 1 ). Therefore, age, gender, income, insurance, BMI categories, and exercise behavior were used as covariates in multivariable analyses comparing outcomes between fibromyalgia and nonfibromyalgia.
Unadjusted comparisons
• Compared with respondents without fibromyalgia, respondents with fibromyalgia had greater absenteeism, presenteeism, overall work impairment, and activity impairment ( Table 2 ).
• Additionally, healthcare resource use (healthcare provider visits, ER visits, and hospitalizations) was higher among respondents with fibromyalgia than respondents without fibromyalgia ( Table 2 ).
• Consequently, respondents with fibromyalgia incurred higher indirect costs and direct costs than respondents without fibromyalgia ( Table 2) .
Adjusted comparisons
• Results from adjusted comparisons were consistent with unadjusted comparisons showing substantially greater economic burden among those with fibromyalgia, compared with those without the condition.
• Those with fibromyalgia experienced nearly 10 times as much absenteeism, twice as much presenteeism, and twice as much overall work impairment. Activity impairment was also twice as high among those with fibromyalgia than for those without fibromyalgia (Figure 1 ).
• For healthcare resource use, respondents with fibromyalgia had nearly three times as many healthcare provider visits, nearly 14 times as many ER visits, and nearly eight times as many hospitalizations (Figure 2 ).
• As a result of greater work productivity loss and healthcare resource use, indirect and direct costs were higher among respondents with fibromyalgia, compared with those without fibromyalgia.
-Specifically, those with fibromyalgia incurred indirect costs that were more than twice as high and direct costs that were nearly six times as high (Figure 3 ).
LIMITATIONS
• Outcomes were self-reported instead of clinically determined, thus, the study's results may be limited due to recall bias.
• Self-selection effects may likewise have biased results; younger, healthier, and/or wealthier respondents may have been more likely to participate in the study, as a function of greater access to the required technology and/or motivation to complete online surveys.
• Causal inferences cannot be made due to the cross-sectional, correlational design of this study; the results may not reflect longer-term changes in the burden of fibromyalgia • Indirect cost estimates used wage information from 2011 and therefore may be outdated and total indirect costs underestimated as a result.
• Finally, the NHWS is designed to be broadly representative of the Japanese adult population. Yet, the degree to which the NHWS represents the adult population with fibromyalgia cannot be confirmed.
CONCLUSIONS
• Compared with Japanese adults without fibromyalgia, those with fibromyalgia had greater work productivity and activity impairment, utilized healthcare resources to greater extent and in turn incurred higher indirect and direct costs.
• Similar to the substantial economic burden associated with fibromyalgia reported in US studies, study findings revealed high costs associated with fibromyalgia in Japan.
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